BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,055 filers reported holding BAXTER INTL INC in Q2 2022. The put-call ratio across all filers is 1.57 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,718 | -35.3% | 125,000 | -21.9% | 2.38% | +39.8% |
| Q2 2023 | $7,290 | +19.8% | 160,000 | +6.7% | 1.70% | -34.8% |
| Q1 2023 | $6,084 | -20.4% | 150,000 | 0.0% | 2.62% | -27.3% |
| Q4 2022 | $7,646 | -99.9% | 150,000 | +25.0% | 3.60% | +0.1% |
| Q3 2022 | $6,463,000 | +54.8% | 120,000 | +84.6% | 3.59% | +51.4% |
| Q2 2022 | $4,175,000 | -10.3% | 65,000 | +8.3% | 2.37% | +23.5% |
| Q1 2022 | $4,652,000 | -27.7% | 60,000 | -20.0% | 1.92% | -30.4% |
| Q4 2021 | $6,438,000 | -30.4% | 75,000 | -34.8% | 2.76% | +24.8% |
| Q3 2021 | $9,249,000 | +64.1% | 115,000 | +64.3% | 2.21% | +100.7% |
| Q2 2021 | $5,635,000 | -16.5% | 70,000 | -12.5% | 1.10% | -55.3% |
| Q1 2021 | $6,747,000 | +12.1% | 80,000 | +6.7% | 2.46% | +0.3% |
| Q4 2020 | $6,018,000 | -12.0% | 75,000 | -11.8% | 2.45% | -16.6% |
| Q3 2020 | $6,836,000 | +100.7% | 85,000 | +466.7% | 2.94% | +118.8% |
| Q1 2020 | $3,406,000 | -41.8% | 15,000 | -78.6% | 1.34% | -38.2% |
| Q4 2019 | $5,853,000 | -10.8% | 70,000 | -6.7% | 2.17% | -34.4% |
| Q3 2019 | $6,560,000 | -5.8% | 75,000 | -11.8% | 3.31% | +96.7% |
| Q2 2019 | $6,962,000 | -18.5% | 85,000 | -19.0% | 1.68% | -46.5% |
| Q1 2019 | $8,538,000 | +116.2% | 105,000 | +75.0% | 3.15% | +47.8% |
| Q4 2018 | $3,949,000 | -36.0% | 60,000 | -25.0% | 2.13% | -3.3% |
| Q3 2018 | $6,167,000 | +4.4% | 80,000 | 0.0% | 2.20% | -3.1% |
| Q2 2018 | $5,907,000 | -9.2% | 80,000 | -20.0% | 2.27% | -25.2% |
| Q1 2018 | $6,504,000 | +0.6% | 100,000 | 0.0% | 3.04% | +26.5% |
| Q4 2017 | $6,464,000 | -14.2% | 100,000 | -16.7% | 2.40% | -6.4% |
| Q3 2017 | $7,530,000 | +24.4% | 120,000 | +20.0% | 2.56% | +15.6% |
| Q2 2017 | $6,054,000 | +6.1% | 100,000 | -9.1% | 2.22% | -16.6% |
| Q1 2017 | $5,705,000 | – | 110,000 | – | 2.66% | – |
| Q4 2016 | $0 | – | 0 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |